Editorial: Functional Characterization and Pharmaceutical Targets in Common and Rare CFTR Dysfunctions

Elena K Schneider-Futschik; Viola H Lobert; John W Wilson

doi:10.3389/fphys.2021.830285

Editorial: Functional Characterization and Pharmaceutical Targets in Common and Rare CFTR Dysfunctions

Front Physiol. 2022 Jan 24:12:830285. doi: 10.3389/fphys.2021.830285. eCollection 2021.

Authors

Elena K Schneider-Futschik¹, Viola H Lobert^{2

3}, John W Wilson^{4

5}

Affiliations

¹ Cystic Fibrosis Pharmacology Laboratory, Department of Biochemistry & Pharmacology, Melbourne University, Melbourne, VIC, Australia.
² Department of Nursing, Health and Laboratory Science, Østfold University College, Fredrikstad, Norway.
³ Department of Mechanical, Electronic and Chemical Engineering, OsloMet, Oslo, Norway.
⁴ Department of Medicine, The Alfred Hospital, Monash University, Melbourne, VIC, Australia.
⁵ Cystic Fibrosis Service, The Alfred Hospital, Melbourne, VIC, Australia.

No abstract available

Keywords: CFTR (cystic fibrosis transmembrane conductance regulator); CFTR (cystic fibrosis transmembrane regulator); biomarker; cystic fibrosis; lung.

Publication types

Editorial